LLY vs. ABBV
Compare and contrast key facts about Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LLY or ABBV.
Key characteristics
| LLY | ABBV | |
|---|---|---|
| YTD Return | 34.23% | 6.94% |
| 1Y Return | 94.09% | 10.10% |
| 3Y Return (Ann) | 64.45% | 18.08% |
| 5Y Return (Ann) | 48.22% | 21.12% |
| 10Y Return (Ann) | 32.27% | 17.01% |
| Sharpe Ratio | 3.30 | 0.65 |
| Daily Std Dev | 30.00% | 18.48% |
| Max Drawdown | -68.27% | -45.09% |
| Current Drawdown | -1.41% | -9.85% |
Fundamentals
| LLY | ABBV | |
|---|---|---|
| Market Cap | $697.40B | $282.63B |
| EPS | $5.79 | $2.71 |
| PE Ratio | 126.69 | 58.90 |
| PEG Ratio | 1.43 | 0.45 |
| Revenue (TTM) | $34.12B | $54.40B |
| Gross Profit (TTM) | $21.91B | $41.53B |
| EBITDA (TTM) | $12.31B | $26.88B |
Correlation
The correlation between LLY and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LLY vs. ABBV - Performance Comparison
In the year-to-date period, LLY achieves a 34.23% return, which is significantly higher than ABBV's 6.94% return. Over the past 10 years, LLY has outperformed ABBV with an annualized return of 32.27%, while ABBV has yielded a comparatively lower 17.01% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LLY vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LLY vs. ABBV - Dividend Comparison
LLY's dividend yield for the trailing twelve months is around 0.60%, less than ABBV's 3.73% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.60% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% | 3.84% |
ABBV AbbVie Inc. | 3.73% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
Drawdowns
LLY vs. ABBV - Drawdown Comparison
The maximum LLY drawdown since its inception was -68.27%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for LLY and ABBV. For additional features, visit the drawdowns tool.
Volatility
LLY vs. ABBV - Volatility Comparison
Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV) have volatilities of 8.49% and 8.35%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LLY vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Eli Lilly and Company and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities